BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Lymphoma

1. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. 5-Sep
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [